-+ 0.00%
-+ 0.00%
-+ 0.00%

Orchestra BioMed Prices $75 Million Public Offering at $5 per Share

PUBT·11/06/2026 03:45:01
Orchestra BioMed Prices $75 Million Public Offering at $5 per Share
  • Orchestra BioMed priced an underwritten public offering of 15,000,000 common shares at $5 per share.
  • Gross proceeds are expected to total $75 million before expenses, excluding the underwriters' option.
  • Underwriters received a 30-day option to purchase up to 2,250,000 additional common shares.
  • The offering is expected to close November 9, 2026, subject to customary closing conditions.
  • Net proceeds will fund AVIM Therapy and Virtue SAB programs, other product development, working capital and general corporate purposes.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Orchestra Biomed Holdings Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611052242PRIMZONEFULLFEED9872018) on November 06, 2026, and is solely responsible for the information contained therein.